Challenges and prospective of enhancing hydatid cyst chemotherapy by nanotechnology and the future of nanobiosensors for diagnosis

S Sadr, N Lotfalizadeh, AM Abbasi… - Tropical medicine and …, 2023 - mdpi.com
Hydatid cysts have been widely recognized for decades as a common medical problem that
affects millions of people. A revolution in medical treatment may be on the prospect of …

Natural products applied against hydatid cyst protoscolices: A review of past to present

MH Kohansal, A Nourian, MT Rahimi, A Daryani… - Acta tropica, 2017 - Elsevier
Echinococcus granulosus is the causative agent of cystic echinococcosis (CE), which is
distributed all around the world. CE is one of the most important global parasitic infectious …

Progress in the pharmacological treatment of human cystic and alveolar echinococcosis: compounds and therapeutic targets

M Siles-Lucas, A Casulli, R Cirilli… - PLoS neglected tropical …, 2018 - journals.plos.org
Human cystic and alveolar echinococcosis are helmintic zoonotic diseases caused by
infections with the larval stages of the cestode parasites Echinococcus granulosus and E …

Ricobendazole nanocrystals obtained by media milling and spray drying: pharmacokinetic comparison with the micronized form of the drug

AJ Paredes, NM Camacho, L Schofs, A Dib… - International Journal of …, 2020 - Elsevier
Helminthic infections are produced by different types of worms and affect millions of people
worldwide. Benzimidazole compounds such as ricobendazole (RBZ) are widely used to treat …

High potency of organic and inorganic nanoparticles to treat cystic echinococcosis: an evidence-based review

AE Albalawi, AD Alanazi, P Baharvand, M Sepahvand… - Nanomaterials, 2020 - mdpi.com
Since there is no potential, effective vaccine available, treatment is the only controlling
option against hydatid cyst or cystic echinococcosis (CE). This study was designed to …

[HTML][HTML] The seroprevalence rate and population genetic structure of human cystic echinococcosis in the Middle East: a systematic review and meta-analysis

TM Galeh, A Spotin, M Mahami-Oskouei… - International Journal of …, 2018 - Elsevier
Cystic echinococcosis (CE) represents an increasing public health concern in many parts of
the world, including the Middle East. The present study is the first systematic review and …

Assessment of the therapeutic efficacy of silver nanoparticles against secondary cystic echinococcosis in BALB/c mice

SM Hamad, BH Shnawa, PJ Jalil, MH Ahmed - Surfaces, 2022 - mdpi.com
Background: Cystic echinococcosis (CE) is a highly prevalent parasitic disease resulting
from the hydatid cyst of Echinococcus granulosus. It is also described as a zoonotic disease …

Status and prospect of novel treatment options toward alveolar and cystic echinococcosis

S Wang, Y Ma, W Wang, Y Dai, H Sun, J Li, S Wang… - Acta Tropica, 2022 - Elsevier
Cystic echinococcosis (CE) and alveolar echinococcosis (AE) are the two most important
global parasitic infectious diseases caused by species of Echinococcus granulosus and E …

Characterization of a multi-epitope peptide with selective MHC-binding capabilities encapsulated in PLGA nanoparticles as a novel vaccine candidate against …

M Roozbehani, R Falak, M Mohammadi, A Hemphill… - Vaccine, 2018 - Elsevier
No effective human vaccine against Toxoplasma gondii (T. gondii) has yet been developed;
however, a protective vaccine using immunogenic peptides in a safe delivery vehicle system …

Nanostructured lipid carriers of ivermectin as a novel drug delivery system in hydatidosis

E Ahmadpour, Z Godrati-Azar, A Spotin, R Norouzi… - Parasites & vectors, 2019 - Springer
Background The larval stage of the tapeworm Echinococcus granulosus is the causative
agent of hydatid disease in humans. This zoonotic parasitic infection remains a major health …